References
- Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. Br. Med. J.328, 977–980 (2004).
- Bartecchi C, Alsever RN, Nevin-Woods C et al. Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation114, 1490–1496 (2006).
- CDC. Reduced hospitalizations for acutemyocardial infarction after implementation of a smoke-free ordinance. City of Pueblo, Colorado. 2002–2006. MMWR Morb. Mortal. Wkly Rep.57, 1373–1377 (2009).
- Juster HR, Loomis BR, HinmanTM et al. Declines in hospital admissions foracute myocardial infarction in New York State after implementation of a comprehensive smoking ban. Am. J. Public Health97, 2035–2039 (2007).
- Seo DC, Torabi MR. Reduced admissions for acute myocardial infarction associated with a public smoking ban: matched controlled study. J. Drug Educ.37, 217–226 (2007).
- Khuder SA, Milz S, Jordan T, Price J, Sivestri K, Butler P. The impact of a smoking ban on hospital admissions for coronary artery disease. Prev. Med.45, 3–8 (2007).
- Lemstra M, Neudorf C, Oponda J. Implications of a public smoking ban. Can. J. Public Health99, 62–65 (2008).
- Barone-Adesi F, Vizzini L, Merletti F, Richiardi L. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur. Heart J.10, 1093–1097 (2006).
- Cesaroni G, Forasteire F, Agabita N, Valente P, Zuccaro P, Perucci CA. Effect of the Italian smoking ban on population rates of acute coronary events. Circulation117, 1183–1188 (2008).
- Vaselli B, Papini P, Gaelone D et al. Reduction incidence of myocardial infarction associated with a national legislative ban on smoking. Minerva Cardioangiol.56, 197–203 (2008).
- Pell JP, Haw S, Cobbe S et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N. Engl. J. Med.359, 482–491 (2008).
- Gasparrini A, Gorini G, Barchielle A. On the relationship between smoking bans and incidence of acute myocardial infarction. Eur. J. Epidemiol.24, 597–602 (2009).
- Cronin E, Kearney P, Kearney P, Sullivan P. Impact of a national smoking ban on the rate of admissions to hospital with acute coronary events. Eur. Heart J.117, 1183 (2007).
- Sautzenberg B. Benefices de l’interdiction de furmer en France. Presented at: European Society of Cardiology. Paris, France, 1–3 May 2008.
- Massachusetts Department of Public Health. Massachusetts sees fewer heart attack deaths since implementation of smoke-free work place law. Press release, Boston, MA, USA, November 2008.
- Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke- free laws and individual risk attributable to secondhand smoke. Circulation120, 1373–1379 (2009).
- Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places. A systematic review and meta-analysis. J. Am. Coll. Cardiol.54, 1249–1255 (2009).
- Clinical Epidemiology. Sackett DL, Haynes RB, Tugwell P (Eds). Little, Brown and Company, Boston/Toronto, USA, 230–234 (1985).
- From association to causation: deriving inferences from epidemiologic studies (Chapter 13). In: Epidemiology. Gordis L (Ed.). WB Saunders Company, PA, USA, 167–182 (1996).
- Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation111, 2684–2698 (2005).
- Husten CG, Thorne SL. Tobacco: health effects and control. In: Public Health and Preventive Medicine (15th Edition). Wallace RB, Kohatsu N (Eds). McGraw Hill, NY, USA, 953–998 (2008).
- Pechacek TF, Babb S. How acute and reversible are the cardiovascular risks of secondhand smoke. Br. Med. J.328, 980–983 (2004).
- Richiardi L, Vizzini L, Merletti F, Barone-Adisi F. Cardiovascular benefits of smoking regulations: the effect of decreased exposure to passive smoking. Prev. Med.48, 167–172 (2009).
- Schmidt P, Karanikas G, Keitz H et al. Passive smoking and platelet thromboxane. Thrombo. Res.81, 451–460 (1996).
- Osuka R, Watanabe H, Hirata K et al. Acute effects of passive smoking on the coronary circulation of healthy young adults. JAMA286, 436–441 (2001).
- Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low density lipoprotein. Circulation97, 2012–2016 (1998).
- Glantz SA, Parmley WW. Passive smoking and heart disease: mechanism and risk. JAMA272, 1047–1053 (1995).
- No authors listed. MRC/BHR Heart Protection study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomized placebo-controlled trial. Lancet360, 7–12 (2002).
- Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease: II: short-term reductions in blood pressure. Overview of randomized drug trials in the epidemiologic context. Lancet335, 827–838 (1990).
- de Lorgeril M, Salen P, Murtin JL et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation99, 779–783 (1999).
Websites
- Shetty KD, DeLeire T, White C, Bhattacharya J. Changes in U.S. hospitalization mortality rates following smoking bans. NBER working paper No. 14790. Nations Bureau of Economic Research, Cambridge, MA, USA (2009) www.nber.org/papers/w14790
- Lambert TA. The case against smoking bans. Missouri Environmental Law and Policy Review, Vol. 13, 2006. University of Missouri Columbia School of Law. Legal studies research paper #2006–2011 http://ssrn.com/abstract=897511
- Newcastle-Ottawa scale for assessing the quality of non-randomized studies in meta-analysis. Ottawa Health Research Institute www.ohri.ca/programs/clinical_epidemiology/oxford.htm